H2020FP7HORIZON
Universitaetsklinikum Hamburg-Eppendorf
- Country
- DEGermany
- Defence projects
- 0
- Projects, all programmes
- 139
- As coordinator
- 59
- EU contribution (CORDIS)
- EUR 99,179,895
- Active
- 2008 to 2025
Projects
139 projects, newest first
| Project | Programme | Year | Role | EU contribution |
|---|---|---|---|---|
| RESOLVEA systems biology approach to RESOLVE the molecular pathology of two hallmarks of patients with metabolic syndrome and its co-morbidities; hypertriglyceridemia and low HDL-cholesterol | FP7 | 2013 | Participant | EUR 792,600 |
| EVERRESTDoes vascular endothelial growth factor gene therapy safely improve outcome in severe early-onset fetal growth restriction? | FP7 | 2013 | Participant | EUR 244,560 |
| CHEMOGUIDEChemotherapy guidance based on efficacy of treatment regimen in cancer cells from the individual patient | FP7 | 2013 | Participant | EUR 253,600 |
| F12Factor XII and the contact system: cross-talk between thrombosis and inflammation | FP7 | 2013 | Participant | EUR 235,800 |
| HBPThe Human Brain Project | FP7 | 2013 | Participant | EUR 99,680 |
| BIODESIGNRational Bioactive Materials Design for Tissue Regeneration | FP7 | 2012 | Participant | EUR 435,467 |
| SUREPIRLPicosecond Infrared Laser for Scarfree Surgery with Preservation of the Tissue Structure and Recognition of Tissue Type and Boundaries | FP7 | 2012 | Participant | EUR 1,373,400 |
| BIO-DrIMPersonalized minimization of immunosuppression after solid organ transplantation by biomarker-driven stratification of patients to improve long-term outcome and health-economic data of transplantation | FP7 | 2012 | Participant | EUR 201,600 |
| CROSS-TALK IN BONEMOLECULAR REGULATION OF OSTEOBLAST MOTILITY AND THE BONE-VASCULAR NICHE | FP7 | 2012 | Coordinator | EUR 100,000 |
| MEREMY6Uncovering the mechanism and physiological relevance of myosin-VI-dependent AMPA receptor trafficking in neurons. | FP7 | 2012 | Coordinator | EUR 100,000 |
| MULTISENSEThe merging of the senses: understanding multisensory experience | FP7 | 2011 | Coordinator | EUR 2,222,400 |
| BIOMARCAREBiomarker for Cardiovascular Risk Assessment in Europe | FP7 | 2011 | Coordinator | EUR 1,255,925 |
| EURHYTHDIAChronotherapeutic lifestyle intervention for diabetes and obesity to reset the circadian rhythm and improve cardiometabolic risk in the European working population | FP7 | 2011 | Coordinator | EUR 1,575,229 |
| EMTICSEuropean Multicentre Tics in Children Studies | FP7 | 2011 | Participant | Not stated |
| EUCogIII3rd European Network for the Advancement of Artificial Cognitive Systems, Interaction and Robotics | FP7 | 2011 | Participant | EUR 54,356 |
| DEM-CHILDA Treatment-Oriented Research Project of NCL Disorders as a Major Cause of Dementia in Childhood | FP7 | 2011 | Coordinator | EUR 876,160 |
| BONE-NETEuropean Training Network on Cancer-Induced Bone Diseases | FP7 | 2011 | Participant | EUR 377,358 |
| eSMCsExtending Sensorimotor Contingencies to Cognition | FP7 | 2011 | Coordinator | EUR 1,033,598 |
| DISSECTDisseminating tumor cells as novel biomarkers: Dissecting the metastatic cascade in cancer patients | FP7 | 2011 | Coordinator | EUR 2,499,000 |
| PLACEBOThe placebo effect – a window into the relationship between mind and body | FP7 | 2011 | Coordinator | EUR 2,499,120 |
The country is the one the source records for the organisation’s registration (its PIC), and each profile says what it rests on. Where the record contradicts itself (the address in one country, the site name and the VAT number in another) we follow the two that agree: the Spanish research council CSIC is shown under Spain although its address is recorded in Italy. A body with sites in several countries is shown under the first of them in alphabetical order, and its profile lists the others. Beyond that we do not guess.
Where this comes from
- CORDIS: EU research projects (Horizon Europe, Horizon 2020, FP7)Last read on . Licence: Commission Decision 2011/833/EU (reuse of Commission documents). Source: CORDIS, European Commission.Participants and amounts as the Commission's CORDIS database states them (reuse under Commission Decision 2011/833/EU).
EU contribution is the amount CORDIS's open data pays to the participant. For a participant with linked third parties it may include their share (the CORDIS page prints the net); an amount the data does not hold is left out, not counted as zero. EDF factsheets state none per participant, so EDF projects count as projects but add nothing to the amounts.
Organisation-level facts only: a name, a country, a role, an amount, a year. A participant is recognised by its PIC where the source gives one, otherwise by name; the page says which. How the data is built.
Names are as CORDIS and the EDF project factsheets publish them. We do not list an organisation whose name looks like a natural person’s. If this entry is you, or a business named after you, and you want it removed, write to the contact in the imprint; the privacy notice (sections 7 and 9) says how a request is handled.